Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis

BACKGROUND: A decade ago, statin persistence was < 50% after 1 year, and recent short-term analyses have revealed very little progress in improving statin persistence, even in patients with a prior cardiovascular (CV) event. Data on longer-term statin persistence are lacking. We measured long-ter...

Descripción completa

Detalles Bibliográficos
Autores principales: Toth, Peter P., Granowitz, Craig, Hull, Michael, Anderson, Amy, Philip, Sephy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747753/
https://www.ncbi.nlm.nih.gov/pubmed/31526399
http://dx.doi.org/10.1186/s12944-019-1099-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747753/
https://www.ncbi.nlm.nih.gov/pubmed/31526399
http://dx.doi.org/10.1186/s12944-019-1099-z

Ejemplares similares